Volume 25, Issue 11, Pages (November 2017)

Slides:



Advertisements
Similar presentations
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Exenatide Reduces Infarct Size and Improves Cardiac.
Advertisements

Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure  William C. Wolf, Hideaki.
Volume 76, Issue 7, Pages (October 2009)
Journal of Molecular and Cellular Cardiology
Journal of Molecular and Cellular Cardiology
Volume 20, Issue 12, Pages (December 2012)
Molecular Therapy - Nucleic Acids
Molecular and Functional Alterations in a Mouse Cardiac Model of Friedreich Ataxia  Michael Li-Hsuan Huang, Sutharshani Sivagurunathan, Samantha Ting,
MicroRNAs Involved in the Mitogen-Activated Protein Kinase Cascades Pathway During Glucose-Induced Cardiomyocyte Hypertrophy  E. Shen, Xuehong Diao, Xiaoxia.
Analysis of Metabolic Remodeling in Compensated Left Ventricular Hypertrophy and Heart FailureClinical Perspective by Takao Kato, Shinichiro Niizuma, Yasutaka.
Activation of Liver-X-Receptor α But Not Liver-X-Receptor β Protects Against Myocardial Ischemia/Reperfusion InjuryCLINICAL PERSPECTIVE by Qing He, Jun.
Volume 24, Issue 5, Pages (November 2013)
Therapeutic Effect of Midkine on Cardiac Remodeling in Infarcted Rat Hearts  Shinya Fukui, MD, Satoru Kitagawa-Sakakida, MD, PhD, Sin Kawamata, MD, PhD,
Volume 78, Issue 3, Pages (August 2010)
Regional remodeling strain and its association with myocardial apoptosis after myocardial infarction in an ovine model  Godfred K. Yankey, MD, Tieluo.
Electron transport chain dysfunction in neonatal pressure-overload hypertrophy precedes cardiomyocyte apoptosis independent of oxidative stress  Eric.
Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3–deficient mice  Denis.
Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure.
Volume 22, Issue 8, Pages (August 2014)
Michael G. Katz, MD, PhD, Elizabeth Brandon-Warner, PhD, Anthony S
Volume 88, Issue 3, Pages (September 2015)
Volume 91, Issue 5, Pages (May 2017)
Volume 25, Issue 4, Pages (April 2017)
Acute, systemic Atg7 deficiency compromises tumorigenesis.
The Efficacy of Cardiac Anti-miR-208a Therapy Is Stress Dependent
Volume 25, Issue 6, Pages (June 2017)
Volume 25, Issue 11, Pages (November 2017)
Volume 134, Issue 3, Pages (March 2008)
Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure  Mark F. Berry, MD, Timothy.
Volume 33, Issue 2, Pages e4 (February 2018)
Lukas J. Motloch et al. BTS 2017;2:
Volume 10, Issue 2, Pages (February 2018)
Blockade of Inflammation and Apoptosis Pathways by siRNA Prolongs Cold Preservation Time and Protects Donor Hearts in a Porcine Model  Jia Wei, Shiyou.
Volume 24, Issue 5, Pages (May 2016)
Quantitative PET Reporter Gene Imaging with [11C]Trimethoprim
Safety and efficacy of high-dose adeno-associated virus 9 encoding sarcoplasmic reticulum Ca2+ adenosine triphosphatase delivered by molecular cardiac.
Volume 82, Issue 4, Pages (August 2012)
Myocyte apoptosis occurs early during the development of pressure-overload hypertrophy in infant myocardium  Yeong-Hoon Choi, MD, Douglas B. Cowan, PhD,
Alberico Luigi Catapano, Angela Pirillo, Giuseppe Danilo Norata 
Hironori Hara et al. BTS 2018;3:
Volume 21, Issue 7, Pages (July 2013)
Volume 9, Issue 5, Pages (May 2009)
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure  William C. Wolf, Hideaki.
Volume 92, Issue 3, Pages (September 2017)
Volume 76, Issue 7, Pages (October 2009)
Genetic deficiency of adiponectin protects against acute kidney injury
Periostin Is a Novel Factor in Cardiac Remodeling After Experimental and Clinical Unloading of the Failing Heart  William E. Stansfield, MD, Nancy M.
Xianyao Xu, MS, Jennifer L. Philip, MD, Md
Jian-jun Wen et al. BTS 2016;j.jacbts
Layered implantation of myoblast sheets attenuates adverse cardiac remodeling of the infarcted heart  Naosumi Sekiya, MD, Goro Matsumiya, MD, PhD, Shigeru.
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 21, Issue 6, Pages (June 2012)
Volume 25, Issue 4, Pages (April 2017)
Volume 25, Issue 3, Pages (March 2017)
Volume 12, Issue 1, Pages (July 2015)
Kasey L Jackson, Robert D Dayton, Ronald L Klein 
Sebastiano Sciarretta et al. JACC 2018;71:
Limiting neutrophilic inflammation during active phase (ZT13) reduces MI damage Limiting neutrophilic inflammation during active phase (ZT13) reduces MI.
Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery  Masaki Tsukashita, MD, Akira Marui, MD, PhD, Takeshi Nishina,
Expression of tomoregulin-1 in wild-type and cardiac hypertrophy mouse myocardium. Expression of tomoregulin-1 in wild-type and cardiac hypertrophy mouse.
Volume 26, Issue 3, Pages (March 2018)
Volume 24, Issue 2, Pages (February 2016)
Hepatocyte Growth Factor Regulates the miR-206-HDAC4 Cascade to Control Neurogenic Muscle Atrophy following Surgical Denervation in Mice  Wooshik Choi,
Quan Jin, Chunping Qiao, Jianbin Li, Juan Li, Xiao Xiao 
Insulin resistance and hepatic steatosis in ASKO mice.
Volume 25, Issue 4, Pages (April 2017)
miR-25 Tough Decoy Enhances Cardiac Function in Heart Failure
Volume 15, Issue 9, Pages (September 2007)
Volume 10, Issue 5, Pages (November 2004)
Volume 26, Issue 5, Pages (May 2018)
Presentation transcript:

Volume 25, Issue 11, Pages 2513-2525 (November 2017) Cholesterol-Lowering Gene Therapy Counteracts the Development of Non-ischemic Cardiomyopathy in Mice  Ilayaraja Muthuramu, Ruhul Amin, Andrey Postnov, Mudit Mishra, Joseph Pierre Aboumsallem, Tom Dresselaers, Uwe Himmelreich, Paul P. Van Veldhoven, Olivier Gheysens, Frank Jacobs, Bart De Geest  Molecular Therapy  Volume 25, Issue 11, Pages 2513-2525 (November 2017) DOI: 10.1016/j.ymthe.2017.07.017 Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 1 Cholesterol-Lowering Gene Therapy Attenuates Cardiac Hypertrophy and Lung Congestion after TAC (A–D) Bar graphs illustrating body weight (A), tibia length (B), heart weight (C), and left ventricular weight (D) in control sham (n = 10), AAV8-LDLr sham (n = 10), control TAC (n = 11), and AAV8-LDLr TAC (n = 11) mice 8 weeks after operation. (E) Left ventricular mass quantified by micro-MRI (n = 6 in each group). (F and G) Left ventricular wall area (F) and cardiomyocyte cross-sectional area (G) quantified by morphometric and histological analysis in control sham (n = 15), AAV8-LDLr sham (n = 22), control TAC (n = 23), and AAV8-LDLr TAC (n = 23) mice 8 weeks after operation. (H and I) Bar graphs showing right ventricular weight (H) and wet lung weight (I) in control sham (n = 10), AAV8-LDLr sham (n = 10), control TAC (n = 11), and AAV8-LDLr TAC (n = 11) mice 8 weeks after operation. Error bars represent SEM. Molecular Therapy 2017 25, 2513-2525DOI: (10.1016/j.ymthe.2017.07.017) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 2 Quantification of Pro-hypertrophic Myocardial Proteins by Western Blot (A–L) Bar graphs illustrating Akt (A), p-Akt (B), mTOR (C), p-mTOR (D), MEK (E), p-MEK (F), ERK (G), p-ERK (H), JNK (I), p-JNK (J), p38 (K), and p-p38 (L) protein levels quantified by western blot in the myocardium of control sham (n = 10), AAV8-LDLr sham (n = 10), control TAC (n = 9), and AAV8-LDLr TAC (n = 10) mice 8 weeks after operation. All protein levels were normalized to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein level. (M) Representative images of western blots are shown. Error bars represent SEM. Molecular Therapy 2017 25, 2513-2525DOI: (10.1016/j.ymthe.2017.07.017) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 3 Cholesterol-Lowering Gene Transfer Significantly Reduces Interstitial Fibrosis and Perivascular Fibrosis after TAC (A and B) Bar graphs illustrating the degree of interstitial fibrosis (A) and the degree of perivascular fibrosis (B) in control sham (n = 15), AAV8-LDLr sham (n = 22), control TAC (n = 23), and AAV8-LDLr TAC (n = 23) mice 8 weeks after operation. (C) Representative photomicrographs showing Sirius-red-stained interstitial collagen viewed under polarized light. Scale bars, 50 μm. (D–G) Bar graphs illustrating the 12.5-kDa isoform of TGF-β1 (D), Smad1 (E), p-Smad1/5 (F), and Smad4 (G) myocardial protein levels quantified by western blot in the myocardium of control sham (n = 10), AAV8-LDLr sham (n = 10), control TAC (n = 9), and AAV8-LDLr TAC (n = 10) mice 8 weeks after operation. All protein levels were normalized to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein level. (H) Representative images of western blots are shown. Error bars represent SEM. Molecular Therapy 2017 25, 2513-2525DOI: (10.1016/j.ymthe.2017.07.017) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 4 Cholesterol Lowering Increases Stroke Volume after TAC (A–D) End-diastolic volume (EDV) (A), end-systolic volume (ESV) (B), stroke volume (C), and ejection fraction (D) in sham mice and in TAC mice (n = 6 for each group). Sham operation or TAC was performed at the age of 17 weeks. Micro-magnetic resonance imaging was performed 8 weeks later. Error bars represent SEM. Molecular Therapy 2017 25, 2513-2525DOI: (10.1016/j.ymthe.2017.07.017) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 5 Cholesterol-Lowering Gene Transfer Counteracts Metabolic Remodeling (A and B) Capillary glucose (A) and plasma insulin levels (B) in control sham (n = 10), AAV8-LDLr sham (n = 10), control TAC (n = 11), and AAV8-LDLr TAC (n = 11) mice 8 weeks after operation. (C and D) Quantification of glucose uptake in the myocardium determined by micro-PET as shown by the maximal standardized uptake (SUV) value (C) and total myocardial uptake (% of injected dose) (D) 8 weeks after sham operation or after TAC (n = 10 in each group). (E) Representative micro-PET images illustrating the uptake of [18F]-FDG in the myocardium of sham mice and TAC mice at day 56 after operation. Error bars represent SEM. Molecular Therapy 2017 25, 2513-2525DOI: (10.1016/j.ymthe.2017.07.017) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 6 Quantification of Metabolic Proteins by Western Blot (A–L) Bar graphs illustrating GLUT4 (A), PDH (B), PDHK (C), AMPK (D), p-AMPK (E), AAC (F), p-ACC (G), PPAR-α (H), CPT1B (I), LXR-α (J), LXR-β (K), and FAS (L) protein levels quantified by western blot in the myocardium of control sham (n = 10), AAV8-LDLr sham (n = 10), control TAC (n = 9), and AAV8-LDLr TAC (n = 10) mice 8 weeks after operation. All protein levels were normalized to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein level. (M) Representative images of western blots are shown. Error bars represent SEM. Molecular Therapy 2017 25, 2513-2525DOI: (10.1016/j.ymthe.2017.07.017) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 7 Oxidative Stress and Myocardial Apoptosis Are Reduced by Cholesterol-Lowering Gene Transfer in Mice with Chronic Pressure Overload (A–C) Bar graphs illustrating plasma TBARSs expressed as plasma malondialdehyde equivalents (A), the percentage of 3-nitrotyrosine-positive area in the myocardium (B), and the number of cleaved caspase-3-positive cells (C) in control sham (n = 15), AAV8-LDLr sham (n = 22), control TAC (n = 23), and AAV8-LDLr TAC (n = 23) mice 8 weeks after operation. (D) Representative photomicrographs showing myocardial sections stained for 3-nitrotyrosine. Scale bars, 100 μm. Error bars represent SEM. Molecular Therapy 2017 25, 2513-2525DOI: (10.1016/j.ymthe.2017.07.017) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions